RMTG
Regenerative Medical Technology Group Inc.
Price Chart
Latest Quote
$0.04
+0.00 (+3.50%)
Current Price
| Previous Close | $0.04 |
| Open | $0.04 |
| Day High | $0.04 |
| Day Low | $0.04 |
| Volume | 45,070 |
Stock Information
| Shares Outstanding | 13.14M |
| Total Debt | $20.58M |
| Cash Equivalents | $1.06M |
| Revenue | $5.10M |
| Net Income | $-7.81M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $544K |
| EPS (TTM) | $-0.63 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $20.04M |
| Sales | $5.10M |
| Income | $-7.81M |
| Book/sh | $-2.40 |
| Cash/sh | $0.08 |
Financial Ratios
| Quick Ratio | 0.03 |
| Current Ratio | 0.03 |
Returns & Margins
| ROA | -11.84% |
| Gross Margin | 55.11% |
| Operating Margin | 9.52% |
| Profit Margin | -153.18% |
Ownership
| Insider Ownership | 8.24% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 0.11 |
| P/B | -0.02 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.03 |
| SMA50 | $0.03 |
| SMA200 | $0.04 |
| RSI | 54.13 |
| ATR | 0.0044 |
| Shares Float | 12.60M |
| Rel Volume | 1.86 |
Performance History
| Week | +3.50% |
| Month | +17.48% |
| Quarter | +44.76% |
| 6 Months | +3.50% |
| YTD | -8.00% |
| Year | +53.33% |
| 3 Years | +245.00% |
| 5 Years | -65.50% |
| 10 Years | -89.65% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-16 | $0.04 | 45,070 |
| 2026-06-15 | $0.04 | 93,959 |
| 2026-06-12 | $0.04 | 0 |
| 2026-06-11 | $0.04 | 10,526 |
| 2026-06-10 | $0.03 | 20,000 |
| 2026-06-09 | $0.04 | 175,000 |
| 2026-06-08 | $0.02 | 1,000 |
| 2026-06-05 | $0.03 | 0 |
| 2026-06-04 | $0.03 | 0 |
| 2026-06-03 | $0.03 | 0 |
| 2026-06-02 | $0.03 | 0 |
| 2026-06-01 | $0.03 | 2,000 |
| 2026-05-29 | $0.04 | 0 |
| 2026-05-28 | $0.04 | 0 |
| 2026-05-27 | $0.04 | 0 |
| 2026-05-26 | $0.04 | 0 |
| 2026-05-22 | $0.04 | 120,934 |
| 2026-05-21 | $0.03 | 0 |
| 2026-05-20 | $0.03 | 0 |
| 2026-05-19 | $0.03 | 15,934 |
| 2026-05-18 | $0.04 | 0 |
About Regenerative Medical Technology Group Inc.
Regenerative Medical Technology Group Inc. operates in the regenerative medicine industry in the United States and internationally. It provides products, solutions, equipment, services, and training to doctors and their staff in the application of stem cell therapies. The company is also involved in the treatment of patients; provision of training and seminars; and resale of kits, products, equipment, and services. In addition, it offers reoccurring application of its process using its kits and solutions. The company was formerly known as Meso Numismatics, Inc. and changed its name to Regenerative Medical Technology Group Inc. in May 2024. Regenerative Medical Technology Group Inc. was incorporated in 1999 and is based in Boca Raton, Florida.
đ° Latest News
No news articles available at the moment. Check back later for updates on RMTG.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,284,375 | $734,285 | $653,256 | $286,950 |
| Cost Of Revenue | $1,284,375 | $734,285 | $653,256 | $287,750 |
| Total Revenue | $4,107,494 | $2,409,953 | $1,530,223 | $437,887 |
| Operating Revenue | $4,107,494 | $2,409,953 | $1,530,223 | $437,887 |
| Expenses | ||||
| Interest Expense | $5,641,609 | $6,491,538 | $4,403,774 | $2,724,351 |
| Total Expenses | $4,026,313 | $3,125,180 | $2,715,082 | $10,357,444 |
| Other Income Expense | $-2,543 | $-2,606,902 | $13,498 | $-227,365 |
| Net Non Operating Interest Income Expense | $-5,641,609 | $-6,491,538 | $-4,403,774 | $-2,724,351 |
| Interest Expense Non Operating | $5,641,609 | $6,491,538 | $4,403,774 | $2,724,351 |
| Operating Expense | $2,741,938 | $2,390,895 | $2,061,826 | $10,069,694 |
| Other Operating Expenses | $52,193 | $9,000 | $190,382 | $100,496 |
| Selling And Marketing Expense | $456,431 | $476,989 | $317,796 | $133,451 |
| General And Administrative Expense | $2,012,755 | $1,594,804 | $1,400,909 | $9,795,689 |
| Other Non Operating Income Expenses | - | $2,463 | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-5,562,971 | $-9,813,666 | $-5,575,135 | $-12,871,273 |
| Net Interest Income | $-5,641,609 | $-6,491,538 | $-4,403,774 | $-2,724,351 |
| Normalized Income | $-5,560,428 | $-7,204,301 | $-5,588,633 | $-12,643,908 |
| Net Income From Continuing And Discontinued Operation | $-5,562,971 | $-9,813,666 | $-5,506,822 | $-12,884,480 |
| Net Income Common Stockholders | $-5,562,971 | $-9,813,666 | $-5,506,822 | $-12,884,480 |
| Net Income | $-5,562,971 | $-9,813,666 | $-5,506,822 | $-12,884,480 |
| Net Income Including Noncontrolling Interests | $-5,562,971 | $-9,813,667 | $-5,506,822 | $-12,884,480 |
| Net Income Continuous Operations | $-5,562,971 | $-9,813,667 | $-5,575,135 | $-12,871,273 |
| Pretax Income | $-5,562,971 | $-9,813,667 | $-5,575,135 | $-12,871,273 |
| Special Income Charges | $0 | $-2,614,163 | $0 | $-231,109 |
| Operating Income | $81,181 | $-715,227 | $-1,184,859 | $-9,919,557 |
| Depreciation Amortization Depletion Income Statement | $220,559 | $310,102 | $152,739 | $40,058 |
| Depreciation And Amortization In Income Statement | $220,559 | $310,102 | $152,739 | $40,058 |
| Gross Profit | $2,823,119 | $1,675,668 | $876,967 | $150,137 |
| Net Income Discontinuous Operations | - | $0 | $68,313 | $-13,207 |
| Per Share | ||||
| Diluted EPS | $-0.44 | $-0.79 | $-0.45 | $-1.12 |
| Basic EPS | $-0.44 | $-0.79 | $-0.45 | $-1.12 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $301,740 | $-402,662 | $-1,032,120 | $-9,878,699 |
| Total Unusual Items | $-2,543 | $-2,609,365 | $13,498 | $-227,365 |
| Total Unusual Items Excluding Goodwill | $-2,543 | $-2,609,365 | $13,498 | $-227,365 |
| Reconciled Depreciation | $220,559 | $310,102 | $152,739 | $40,858 |
| EBITDA (Bullshit earnings) | $299,197 | $-3,012,027 | $-1,018,622 | $-10,106,064 |
| EBIT | $78,638 | $-3,322,129 | $-1,171,361 | $-10,146,922 |
| Diluted Average Shares | $12,531,586 | $12,447,089 | $12,219,502 | $11,482,399 |
| Basic Average Shares | $12,531,586 | $12,447,089 | $12,219,502 | $11,482,399 |
| Diluted NI Availto Com Stockholders | $-5,562,971 | $-9,813,666 | $-5,506,822 | $-12,884,480 |
| Impairment Of Capital Assets | $0 | $4,125,460 | $0 | - |
| Gain On Sale Of Security | $-2,543 | $4,798 | $13,498 | $3,744 |
| Selling General And Administration | $2,469,186 | $2,071,793 | $1,718,705 | $9,929,140 |
| Other Gand A | $1,922,755 | $1,504,804 | $1,310,909 | $9,232,617 |
| Salaries And Wages | $90,000 | $90,000 | $90,000 | $563,072 |
| Other Special Charges | - | $-1,511,297 | - | $231,109 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-29,195,655 | $-23,732,025 | $-18,141,814 | $-13,014,068 |
| Total Assets | $3,821,429 | $2,879,103 | $8,080,273 | $9,305,566 |
| Total Non Current Assets | $2,573,204 | $2,304,107 | $6,385,322 | $6,285,539 |
| Other Non Current Assets | $7,264 | $5,568 | $5,568 | $5,568 |
| Goodwill And Other Intangible Assets | $1,838,982 | $1,936,522 | $6,159,522 | $6,257,062 |
| Other Intangible Assets | $159,004 | $256,544 | $354,084 | $451,624 |
| Current Assets | $1,248,225 | $574,996 | $1,694,951 | $3,020,027 |
| Prepaid Assets | $49,685 | $20,500 | $0 | $24,245 |
| Inventory | $10,115 | $0 | - | - |
| Receivables | $22,605 | $23,956 | $49,766 | $17,256 |
| Accounts Receivable | $22,605 | $23,956 | $49,766 | $17,256 |
| Allowance For Doubtful Accounts Receivable | $0 | $0 | $0 | $0 |
| Gross Accounts Receivable | $22,605 | $23,956 | $49,766 | $17,256 |
| Cash Cash Equivalents And Short Term Investments | $1,165,820 | $530,540 | $1,645,185 | $2,978,525 |
| Cash And Cash Equivalents | $1,165,820 | $530,540 | $1,645,185 | $2,978,525 |
| Other Current Assets | - | - | - | $1 |
| Debt | ||||
| Net Debt | $18,608,049 | $17,118,450 | $13,463,030 | $10,645,240 |
| Total Debt | $20,049,125 | $17,651,704 | $15,142,178 | $13,623,765 |
| Long Term Debt And Capital Lease Obligation | $2,211,715 | $2,425,471 | $8,062,944 | $11,844,518 |
| Long Term Debt | $1,999,999 | $2,425,471 | $8,061,549 | $11,844,518 |
| Current Debt And Capital Lease Obligation | $17,837,410 | $15,226,233 | $7,079,234 | $1,779,247 |
| Current Debt | $17,773,870 | $15,223,519 | $7,046,666 | $1,779,247 |
| Other Current Borrowings | $17,773,870 | $15,223,519 | $7,046,666 | $1,779,247 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $31,178,102 | $24,674,606 | $20,062,565 | $16,062,572 |
| Total Non Current Liabilities Net Minority Interest | $2,211,716 | $2,425,471 | $8,062,944 | $11,844,517 |
| Other Non Current Liabilities | $1 | - | - | $-1 |
| Current Liabilities | $28,966,386 | $22,249,135 | $11,999,621 | $4,218,055 |
| Other Current Liabilities | $4,688 | $2,146 | $6,944 | $89,756 |
| Current Deferred Liabilities | $55,684 | $2,000 | $10,450 | $18,215 |
| Payables And Accrued Expenses | $11,068,604 | $7,018,756 | $4,902,993 | $2,330,837 |
| Interest Payable | $9,796,982 | $6,597,422 | $4,657,530 | $2,129,395 |
| Payables | $1,271,622 | $421,334 | $245,463 | $201,442 |
| Accounts Payable | $1,271,622 | $421,334 | $245,463 | $181,442 |
| Other Payable | - | - | - | $20,000 |
| Equity | ||||
| Common Stock Equity | $-27,357,733 | $-21,796,563 | $-11,983,352 | $-6,758,066 |
| Preferred Stock Equity | $1,060 | $1,060 | $1,060 | $1,060 |
| Total Equity Gross Minority Interest | $-27,356,673 | $-21,795,503 | $-11,982,292 | $-6,757,006 |
| Stockholders Equity | $-27,356,673 | $-21,795,503 | $-11,982,292 | $-6,757,006 |
| Retained Earnings | $-67,553,102 | $-61,990,131 | $-52,176,465 | $-46,669,643 |
| Preferred Securities Outside Stock Equity | - | - | - | $0 |
| Other | ||||
| Ordinary Shares Number | $12,538,968 | $12,493,938 | $12,443,938 | $12,085,125 |
| Share Issued | $12,538,968 | $14,096,252 | $12,443,938 | $13,687,439 |
| Tangible Book Value | $-29,196,715 | $-23,733,085 | $-18,142,874 | $-13,015,128 |
| Invested Capital | $-7,583,864 | $-4,147,573 | $3,124,863 | $6,865,699 |
| Working Capital | $-27,718,161 | $-21,674,139 | $-10,304,670 | $-1,198,028 |
| Capital Lease Obligations | $275,256 | $2,714 | $33,963 | $0 |
| Total Capitalization | $-25,356,674 | $-19,370,032 | $-3,920,743 | $5,087,512 |
| Additional Paid In Capital | $40,182,830 | $40,181,074 | $40,180,669 | $39,899,491 |
| Capital Stock | $13,599 | $13,554 | $13,504 | $13,146 |
| Common Stock | $12,539 | $12,494 | $12,444 | $12,086 |
| Preferred Stock | $1,060 | $1,060 | $1,060 | $1,060 |
| Long Term Capital Lease Obligation | $211,716 | $0 | $1,395 | $0 |
| Current Deferred Revenue | $55,684 | $2,000 | $10,450 | $18,215 |
| Current Capital Lease Obligation | $63,540 | $2,714 | $32,568 | $0 |
| Current Accrued Expenses | $9,796,982 | $6,597,422 | $4,657,530 | $2,129,395 |
| Goodwill | $1,679,978 | $1,679,978 | $5,805,438 | $5,805,438 |
| Net PPE | $726,958 | $362,017 | $220,232 | $22,909 |
| Accumulated Depreciation | $-431,717 | $-308,697 | $-96,135 | $-43,536 |
| Gross PPE | $1,158,675 | $670,714 | $316,367 | $66,445 |
| Leases | $977,123 | $503,940 | $167,171 | $0 |
| Machinery Furniture Equipment | $181,552 | $166,774 | $149,196 | $66,445 |
| Properties | $0 | $0 | $0 | $0 |
| Treasury Shares Number | - | $1,602,314 | - | $1,602,314 |
| Other Properties | - | - | $33,963 | - |
| Buildings And Improvements | - | - | $33,963 | $0 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $635,280 | $-804,795 | $-1,312,564 | $-9,878,664 |
| Operating Activities | ||||
| Operating Cash Flow | $850,699 | $-419,199 | $-1,114,136 | $-9,878,664 |
| Cash Flow From Continuing Operating Activities | $850,698 | $-419,200 | $-1,114,136 | $-9,878,664 |
| Operating Gains Losses | $2,543 | $-1,518,558 | $-13,498 | $-3,744 |
| Investing Activities | ||||
| Capital Expenditure | $-215,419 | $-385,596 | $-198,428 | - |
| Investing Cash Flow | $-215,419 | $-385,596 | $-198,428 | $666,467 |
| Cash Flow From Continuing Investing Activities | $-215,419 | $-385,596 | $-198,428 | $666,467 |
| Financing Activities | ||||
| Financing Cash Flow | $0 | $-309,850 | $-20,776 | $12,148,188 |
| Cash Flow From Continuing Financing Activities | $0 | $-309,850 | $-20,776 | $12,148,188 |
| Repurchase Of Capital Stock | - | - | - | $0 |
| Net Other Financing Charges | - | - | - | $-250,000 |
| Net Preferred Stock Issuance | - | - | - | $0 |
| Other | ||||
| Repayment Of Debt | $0 | $-309,850 | $-20,776 | $-1,812 |
| Interest Paid Supplemental Data | $0 | $446 | $283 | $208 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | $0 |
| End Cash Position | $1,165,820 | $530,540 | $1,645,185 | $2,978,525 |
| Beginning Cash Position | $530,540 | $1,645,185 | $2,978,525 | $42,534 |
| Changes In Cash | $635,280 | $-1,114,645 | $-1,333,340 | $2,935,991 |
| Net Issuance Payments Of Debt | $0 | $-309,850 | $-20,776 | $12,398,188 |
| Net Long Term Debt Issuance | $0 | $-309,850 | $-20,776 | $12,398,188 |
| Long Term Debt Payments | $0 | $-309,850 | $-20,776 | $-1,812 |
| Net PPE Purchase And Sale | $-215,419 | $-385,596 | $-198,428 | $0 |
| Purchase Of PPE | $-215,419 | $-385,596 | $-198,428 | $0 |
| Change In Working Capital | $4,063,887 | $3,417,093 | $2,485,281 | $1,545,861 |
| Change In Other Current Assets | $-1,696 | $0 | $0 | $-5,568 |
| Change In Payables And Accrued Expense | $4,103,532 | $3,411,783 | $2,517,791 | $1,578,924 |
| Change In Prepaid Assets | $-29,185 | $-20,500 | $0 | $-24,245 |
| Change In Inventory | $-10,115 | $0 | - | - |
| Change In Receivables | $1,351 | $25,810 | $-32,510 | $-3,250 |
| Changes In Account Receivables | $1,351 | $25,810 | $-32,510 | $-3,250 |
| Other Non Cash Items | $2,126,681 | $3,060,370 | $1,836,477 | $1,409,634 |
| Asset Impairment Charge | $0 | $4,125,460 | $0 | - |
| Depreciation Amortization Depletion | $220,559 | $310,102 | $152,739 | $40,858 |
| Depreciation And Amortization | $220,559 | $310,102 | $152,739 | $40,858 |
| Amortization Cash Flow | $97,540 | $97,540 | $97,540 | - |
| Amortization Of Intangibles | $97,540 | $97,540 | $97,540 | - |
| Depreciation | $123,020 | $212,562 | $55,199 | - |
| Gain Loss On Investment Securities | $2,543 | $-4,798 | $-13,498 | $-3,744 |
| Net Income From Continuing Operations | $-5,562,971 | $-9,813,666 | $-5,575,135 | $-12,871,273 |
| Issuance Of Debt | - | - | $0 | $12,400,000 |
| Long Term Debt Issuance | - | - | $0 | $12,400,000 |
| Net Business Purchase And Sale | - | - | $0 | $666,467 |
| Sale Of Business | - | - | $0 | $666,467 |
| Change In Payable | - | - | $2,517,791 | $1,578,924 |
| Change In Account Payable | - | - | $2,517,791 | $1,307,388 |
| Preferred Stock Payments | - | - | - | $0 |
| Purchase Of Business | - | - | - | $0 |
Fetched: 2026-02-02